Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Fosun International Garners Four Awards from Corporate Governance Asia 2024-06-04 18:20
Qingsong Health Corporation Elevates Healthcare and Inclusive Development with AI Advancements at WSIS+20 Forum 2024-06-04 16:04
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications 2024-06-04 13:30
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
Live from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety 2024-06-04 12:51
Fapon Biopharma Announces a Safer Immunotherapy for Cancers 2024-06-04 09:42
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 2024-06-04 09:38
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer 2024-06-04 08:00
Optimi Health Awarded Drug Establishment Licence From Health Canada 2024-06-03 23:49
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx 2024-06-03 23:37
Datasea Agreement already provided $2.8 million Information Service for its Highly Specialized 5G-AI Communications Platform 2024-06-03 22:00
Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for the Treatment of Patients with Recurrent or Metastatic Solid Tumors at the 2024 ASCO Annual Meeting 2024-06-03 21:30
Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens at BIO Conference in San Diego 2024-06-03 20:00
HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024 2024-06-03 20:00
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint 2024-06-03 13:01
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest 2024-06-03 11:35
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Annual Meeting. 2024-06-03 10:57
Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting 2024-06-03 10:17
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting 2024-06-03 09:44
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer 2024-06-03 09:35
1 58 59 60 61 62 962